SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-027306
Filing Date
2024-02-26
Accepted
2024-02-26 08:18:41
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm246927-1_424b5.htm 424B5 334743
2 EX-FILING FEES tm246927d2_ex-filingfees.htm EX-FILING FEES 16407
3 GRAPHIC lg_celldextherapeutics-4c.jpg GRAPHIC 16646
4 GRAPHIC lg_cantor-4c.jpg GRAPHIC 10459
  Complete submission text file 0001104659-24-027306.txt   390027
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275300 | Film No.: 24673635
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)